PediatricsConsultantLive Members: Login | Register
PediatricsConsultantLive SearchMedica Medline Drugs

Powered by SearchMedica

 
About Us
Blog
Dermclinic
Photoclinic
Is It Child Abuse?
Multimedia
What's Your Diagnosis?
To ConsultantLive
Buyer's Guide
 

Home » Topic Centers » Skin Diseases

Consultant for Pediatricians. Vol. 10 No. 3
Pages: 1  2  
Previous
Dermclinic 

Would you continue acne therapy for a teenage boy with severe scarring?

By Kirk Barber, MD, FRCPC––Series Editor
Alberta Children’s Hospital | March 1, 2011
Dr Barber is a consultant dermatologist at Alberta Children's Hospital and clinical associate professor of medicine and community health sciences at the University of Calgary in Alberta.

Dermclinic–Answer
Yes, the primary treatment of the keloids in this patient is acne management; however, it must be stressed that the scars are permanent.

The term “keloid” is derived from the Greek word chele, which means crab claw. The crab claw is clearly evident on this boy's chest. A keloid former, such as this patient, probably has a genetic predisposition for this skin response. Keloids may affect all races and any site of the body. They are more common in dark-skinned children, in adolescence, and in certain areas (the anterior chest, shoulders, posterior neck, and earlobes). They usually develop after a skin injury, particularly thermal injury, or within wounds under tension. Keloids may also develop spontaneously, without a history of obvious injury or inflammation, particularly on the anterior chest.

It is useful to differentiate keloids from hypertrophic scars because the treatment and prognosis are quite different. Both types of scarring start as inflammatory lesions in the wound and usually produce an itching or burning sensation. The hypertrophic scar remains confined to the wound margin, whereas the keloid extends beyond the wound margin and often exhibits expanding, thick, inflammatory borders with central clearing; hence, the term “crab claw.” Hypertrophic scars tend to improve over time and respond quickly to intralesional corticosteroid therapy. Keloids are progressive and respond poorly to all forms of intervention.

The primary treatment of keloids is to stop the inflammatory insult. For this teenage boy, I chose to treat his acne with a second course of isotretinoin(Drug information on isotretinoin). Simultaneously, I began intralesional corticosteroid therapy with triamcinolone(Drug information on triamcinolone) acetonide, at both 10 mg/mL and 40 mg/mL concentrations depending on the keloid density. The injection technique requires luer lock syringes; significant resistance during injection ensures placement of the corticosteroid in the keloid. For particularly dense keloids, I pretreat the lesion with cryosurgery to produce tissue swelling, which allows for easier penetration of the corticosteroid. I am also encouraging him to apply silicone gel both as sheeting and as a topical ointment. His treatment is likely to be a mutli-year project. I anticipate that he will be able to wear T-shirts without bumps showing through; however, he will always have the scars. I stress this to him at every visit to avoid creating unrealistic expectations of what I can do for him.

The medical literature reports a variety of other treatment options. Unfortunately, the trials are usually small and the results do not document the long-term success of the treatments. Pulsed dye laser, radiation, intralesional interferon, and intralesional 5-fluorouracil are the most common alternatives.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Christona Lewis | April 20, 2011 3:15 PM EDT

Gary said this case is not for a primary care doctor to handle alone. I am a primary care nurse practitioner and nationally certified dermatology nurse. I treat these types of patients. We do not do laser at our college health center but the triamcinolone injections and the isotretinoin teaching and follow up are done at our clinic without referral. Depends on how often you come across this problem.

by Christona Lewis | April 20, 2011 3:11 PM EDT

With this amount of scarring, I would lett him know the options of scar treatment and the probability of sucess and having him choose treatment after the triamcinolone injections are completed and the keloids are not enlarging. Being a knowledgable consumer is important. Great job in continously reviewing that his skin will never be completely without scars. Sometimes they need that reinforcement.

by Gary Melvin Gorlick | March 23, 2011 5:06 PM EDT

Kudos to the author here. Nice discussion. And a case not for the primary doctor to handle alone.

by Corky Smith | March 23, 2011 2:41 PM EDT

Unfortunately, my connection will NOT progress to the next page . . . a problem with almost every one of these discussion pages: if it even opens, it then dead ends instead of opening the subsequent page. Infuriating.
However, with NO further information, I would continue the isotretinoin as there are still active lesions present.






 
TOPIC INDEX

• ADHD
• Allergy
• Asthma
• Atopic Dermatitis
• Autism
• Bacterial Conjunctivitis
• Developmental/Genetic Disorders
• Epilepsy
• Failure to Thrive
• Food Allergies
• GI Disorders
• Lice Treatments
• Obesity
• Respiratory Tract Diseases
• Sexually Transmitted Infections
• Skin Diseases
• Vaccines
• Vitamin D Insufficiency


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Diaper Dermatoses: A Photo Essay
  • Galactorrhea of the Newborn (Witch’s Milk)
  • Genital Lesions: A Photo Essay—Part 2
  • Genital Lesions: A Photo Essay
  • Perianal Pinworms (Enterobiasis)
  • Itchy, Acne-Like Rash on a Boy’s Face and Upper Arms
  • Diaper Dermatoses: A Photo Essay
  • Selective IgA Deficiency in Children: Clinical Manifestations, Evaluation, and Management
  • Top 10 Common Medication Errors -- Drug #7 -- Ciprofloxacin
  • An Overview of Chronic Cough in Children
  • Common Medication Errors: Drug #6: Ketorolac
  • Cellulitis-Adenitis From Late-Onset Group B Streptococcus Infection
  • Go for the Glory: Pediatrics Quiz of the Week
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Top 10 Common Medication Errors—Drug #8: Carbamazepine
  • Top 10 Common Medication Errors—Drug #8: Carbamazepine
  • Top 10 Common Medication Errors—Drug #1: Acetaminophen
  • Go for the Glory: Pediatrics Quiz of the Week
  • History of Cough in an Infant and a Toddler
  • Genital Lesions: A Photo Essay
Click here to subscribe to our newsletter


 

 



CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy